Source: Virtual Congress 2021 – Biological and functional markers of COVID-19



Rating:

Share or cite this content

Citations should be made in the following way:
R. Cherneva (Sofia, Bulgaria), Z. Cherneva (Sofia, Bulgaria). Neutrophil-to-lymphocyte, platlet-to-lymphocyte ratio and adiposityin early COVID -19. 3883

Member's Comments

No comment yet.

Related content which might interest you: FEV1/FEV3 ratio as an alternative to fixed ratio of FEV1/FVC Source: International Congress 2018 – Biomarkers and lung function in airway disease Year: 2018 Are white blood cells count, neutrophil-to-lymphocyte ratio, lymphocyte to monocyte ratio and platelet-to-lymphocyte ratio associated with severe COVID-19 infection? Source: Virtual Congress 2021 – COVID - 19 Year: 2021 Prognostic value of haematological markers such as neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) in small cell lung cancer. Source: Virtual Congress 2020 – Prognostic and predictive factors: treatment of lung cancer Year: 2020 Platelet-to-lymphocyte ratio (PLR) as a predictor of Covid-19 pneumonia progression Source: Virtual Congress 2021 – COVID - 19 biomarkers Year: 2021 Neutrophil-to-lymphocyte ratio and COPD exacerbations in the TIE-study Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases Year: 2020 Lymphocyte-to-monocyte ratio (LMR) as a predictor of Covid-19 pneumonia progression Source: Virtual Congress 2021 – COVID - 19 biomarkers Year: 2021 Lymphocyte-to-Monocyte ratio (LMR) and Platelet-to-lymphocyte (PLR) ratio levels as a predictors of lung failure in severe Covid-19 pneumonia patients (pts) Source: Virtual Congress 2021 – COVID - 19: lessons learned Year: 2021 Neutrophil-to-lymphocyte ratio in IPF patients: a novel prognostic biomarker? Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis Year: 2020 Malignant mesothelioma, are neutrophil/lymphocyte ratio and platelet/lymphocyte ratio prognostic indicator parameters as reliable? Source: International Congress 2015 – Mediastinal tumors, malignant pleural mesothelioma and other rare tumors Year: 2015 Changes in the FEV1/FVC ratio during childhood and adolescence: an intercontinental study Source: Eur Respir J 2010; 36: 1391-1399 Year: 2010 The ratio of lean-to-fat mass and functional limitation in COPD Source: Eur Respir J 2006; 28: Suppl. 50, 452s Year: 2006 Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes Source: Eur Respir J 2008; 31: 349-355 Year: 2008 Divergent expression of claudin -1, -3, -4, -5 and -7 in developing human lung Source: Annual Congress 2009 - Hot topics in molecular pathology and functional genomics of COPD Year: 2009 Predictive value of unassisted respiratory rate-tidal volume ratio (RVR) in weaning outcome Source: Eur Respir J 2001; 18: Suppl. 33, 239s Year: 2001 In obese healthy women: body mass index, waist circumference, spirometry and diffusion Source: Eur Respir J 2006; 28: Suppl. 50, 656s Year: 2006 PaO2/FIO2 ratio: the mismeasure of oxygenation in COVID-19 Source: Eur Respir J, 57 (3) 2100274; 10.1183/13993003.00274-2021 Year: 2021 Defining the role of neutrophil-to-lymphocyte ratio in COPD patients Source: Virtual Congress 2020 – Prognosis and integrated management of COPD Year: 2020 Predictive value of Neutrophil-to-lymphocyte ratio(NLR) and Platelet-to-lymphocyte ratio(PLR) in patients with Sarcoidosis Source: International Congress 2018 – Granulomatous disorders: heterogeneous diseases with variable management Year: 2018 Neutrophil-to-lymphocyte ratio, blood eosinophils and COPD exacerbations: a cohort study Source: ERJ Open Res, 7 (4) 00471-2021; 10.1183/23120541.00471-2021 Year: 2021 Fixed ratio or lower limit of normal for the FEV1/VC ratio: Relation to symptoms and extended lung function tests Source: Annual Congress 2013 –Assessing the prevalence of COPD in the general population Year: 2013